Lantern Pharma Shares Rise 2.34% as Nasdaq Biotech Stock Surges
Lantern Pharma’s Nasdaq shares rose 2.34% to $0.66, spotlighting its AI‑driven oncology research and clinical‑stage pipeline—see 2026 market snapshot.
- LANTERN PHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read